We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 10

Buy more, save more: exclusivity conditions, loyalty rebates, and competition law

  • Clayton Utz
  • -
  • Australia, USA
  • -
  • May 9 2013

It can sometimes be unlawful for a supplier with a strong market position to offer its customers long-term supply terms with volume rebates which are

New house for the random penguin gets the nod

  • King & Wood Mallesons
  • -
  • Australia, European Union, New Zealand, USA
  • -
  • April 9 2013

The clearances keep coming with the Unites States, Australia, New Zealand and the European Union's competition authorities having all unconditionally

Criminal and related antitrust developments in 2012: Canada and the world

  • Fasken Martineau DuMoulin LLP
  • -
  • Australia, Canada, China, European Union, India, Japan, New Zealand, South Korea, United Kingdom, USA
  • -
  • April 2 2013

This article outlines the major global criminal and related antitrust developments in 2012, with a focus on Canada. Three salient realities

Global guide to competition litigation

  • Baker & McKenzie
  • -
  • Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Czech Republic, France, Germany, Hungary, India, Italy, Japan, Mexico, Netherlands, Poland, Russia, Spain, Sweden, Switzerland, Turkey, United Kingdom, USA
  • -
  • October 1 2012

Competition litigation is a fast growing and complex area of commercial litigation that often requires coordination of strategy across jurisdictions

Managing your risks under global anti-corruption regimes

  • Piper Alderman
  • -
  • Australia, United Kingdom, USA
  • -
  • September 13 2012

Pharmaceutical and medical device companies operate in a stringent regulatory environment

European Commission ups the cost of paying for delay

  • King & Wood Mallesons
  • -
  • Australia, European Union, USA
  • -
  • August 13 2012

On 25 July 2012, the EC alleged that Danish pharmaceutical company Lundbeck violated EU antitrust rules by colluding to prevent other pharma companies from marketing generic versions of its best-seller antidepressant, citalopram

Competition highlights - ASEAN & beyond

  • Rajah & Tann LLP
  • -
  • Australia, China, European Union, India, Indonesia, Malaysia, Singapore, South Korea, United Kingdom, USA, Vietnam
  • -
  • January 20 2012

Happy New Year!

New fault lines in international cartel enforcement and administration of leniency programs disclosure of immunity applicant statements

  • Latham & Watkins LLP
  • -
  • Australia, European Union, United Kingdom, USA
  • -
  • January 19 2012

Recent rulings by courts in a number of jurisdictions (UK, Australia, United States, and the European Union) are resulting in increased disclosure of oral statements and interview materials produced by leniency applicants

Competition regulators continue their campaign against pharmaceutical companies

  • King & Wood Mallesons
  • -
  • Australia, USA
  • -
  • June 1 2011

Last month, the US Federal Trade Commission (FTC) released its findings on reverse payment settlements between pharmaceutical companies in the 2010 US fiscal year

International regulatory update 7 - 11 March 2011

  • Clifford Chance LLP
  • -
  • Australia, Belgium, European Union, Global, Japan, Netherlands, Philippines, United Kingdom, USA
  • -
  • March 14 2011

IOSCO and the Committee on Payment and Settlement Systems (CPSS) have published a consultative report setting out a new set of principles designed to apply to all systemically important payment systems, central securities depositories, securities settlement systems, central counterparties and trade repositories

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy